Advertisement
U.S. approves monthly injection for opioid addiction

U.S. approves monthly injection for opioid addiction

By Associated Press  |  December 01, 2017

The monthly injection has the potential to reduce dangerous relapses that occur when patients stop taking the currently available daily medication. But that benefit has not yet been shown in studies and the new drug comes with a hefty price: $1,580 per monthly dose.

FDA to pave clearer path for generic drugs

FDA to pave clearer path for generic drugs

By Alex Kacik  |  November 29, 2017

The FDA's new guidance aims to make it easier for generic firms to plan how they can copy complex drugs like epinephrine auto-injectors, which should ultimately lower pharmaceutical prices.

U.S. regulators approve second gene therapy for blood cancer

U.S. regulators approve second gene therapy for blood cancer

By Associated Press  |  October 19, 2017

Kite Pharma's newly approved blood cancer treatment, Yescarta, uses gene therapy techniques not to fix disease-causing genes but to turbocharge T cells, immune system soldiers that cancer can often evade.

FDA requires opioid makers to develop doctor training

By Associated Press  |  September 29, 2017

The agency notified 74 manufacturers of so-called immediate-release opioids that their drugs will now be subject to the tougher requirements, although doctors would not be compelled to take part in the training.

Advertisement
X

Subscribe and SAVE 50%

View our best offer
Subscribe to Print